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Pulsatile perfusion during cardiopulmonary bypass
To the Editor:
I read with interest the article by Kawahara and associates
from Saitama, Japan, titled “Induced Pulsatile Perfusion
During Cardiopulmonary Bypass Does Not Improve Brain
Oxygenation” (J Thorac Cardiovasc Surg 1999;118:361-6).
The article should be retitled “Balloon Pump–Induced
Pulsatile Perfusion During Cardiopulmonary Bypass Does
Not Alter Brain Oxygenation” because, as applied in this
study, there were no substantial effects of the balloon pump
on any of the measured parameters.
Perhaps this is because the balloon did not augment the
pulse pressure significantly enough (24 ± 8 mm Hg) during
cardiopulmonary bypass. Had the pulse pressure been 40 mm
Hg or more, positive readings might have occurred. No hemo-
dynamic blood pressure tracings accompanied the article.
One clear measurement of intra-aortic balloon pump effi-
cacy during cardiopulmonary bypass is the simple measure-
ment of urinary output during successful pulsatile augmenta-
tion. Many1,2 studies have shown that when pulsatile flow is
successfully applied, the urinary output usually doubles. Was
this the case in this study?
Rather than suggest that the lack of improvement in brain
oxygenation was a result of the negative (or no) effect of pul-
satile perfusion, perhaps the authors should reexamine the
basic application of the balloon pump in the cardiopulmonary
bypass setting for the creation of pulsatile flow to determine
whether it was really applied effectively in their study.
David Bregman, MD, FACS, FACC
Thoracic and Cardiovascular Surgery
The Point of Aventura-North Tower
21205 Yacht Club Dr, PH 3205
Aventura, FL 33180
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Reply to the Editor:
We appreciate the interest and comments of Dr Bregman.
We agree that pulsatility offers advantages over nonpulsatili-
ty to reduce requirements for postoperative inotropic support
and intra-aortic balloon counterpulsation (IABP), as reported
by Bregman and colleagues.1 Furthermore, Murkin and asso-
ciates2 reported that the duration of cardiopulmonary bypass
(CPB), age, and use of nonpulsatile perfusion correlated sig-
nificantly with adverse outcome. However, it still remains
controversial whether pulsatility offers advantages over non-
pulsatility for brain protection.3
The pulse pressure used in our study (24 ± 8 mm Hg) was
determined to obtain the physiologic dP/dt value. Since we
did not examine the pulse pressure as recommended by
Bregman (>40 mm Hg), further study with higher pulse pres-
sure is required to evaluate the effect of high-pressure IABP
on cerebral circulation.
Since the hemofiltration system was connected to the CPB
circuit to increase hemoglobin concentration during CPB in
most cases in our institutes, exact urinary output could not be
examined during CPB. However, we also have the impression
that pulsatile perfusion has a beneficial effect on renal blood
flow.
Cook, Orszulak, and Daly4 reported that pulsatility gener-
ated by IABP, with a pulse pressure of approximately 30 mm
Hg, had no significant effect on cerebral perfusion. Lodge
and associates5 also could not show any benefits of pulsatile
perfusion on regional or global cerebral blood flow. Their
pulse pressure was 36 ± 6 mm Hg. In contrast, several
reports1 including the study by Dr Bregman showed benefits
of pulsatile perfusion. At present, it is not clear which type of
pulsatile wave form has positive effects on cerebral circula-
tion and improves the outcome of patients. We admit that
another type of pulse wave might be effective to alter brain
oxygenation.
Yuji Kadoi, MD
Shigeru Saito, MD
Department of Anesthesiology and Reanimatology
Gunma University School of Medicine
3-39-22, Showa-machi
Maebashi, Gunma 371-8511 Japan
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